These emerging medications , Tirzepatide , represent a remarkable advancement in managing type 2 diabetes and potentially other disorders. They all are classified as GLP-1 pathway stimulators, signifying they to replicate the natural GLP-1 hormone , boosting insulin secretion and suppressing food intake. Although Retatrutide each works largely simi